查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1475212

全球癌症基因治疗市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势和预测

Global Cancer Gene Therapy Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

全球癌症基因治疗市场需求预计将从2023年的31.1亿美元达到近161亿美元的市场规模，2024年至2032年的研究期间复合年增长率为20.05%。

癌症基因治疗利用基因技术，透过标靶参与肿瘤生长、进展和存活的特定基因或细胞途径来治疗癌症。这种治疗方法旨在修改或抑制癌症相关基因，刺激针对癌细胞的免疫反应，或将治疗基因直接传递到肿瘤中以抑制其生长或诱导细胞死亡。这种疗法有望成为包括实体瘤和血液恶性肿瘤在内的各种类型癌症的潜在治疗选择，与传统化疗和放射疗法相比，具有降低毒性的标靶和个人化干预的潜力。

市场动态

全球范围内癌症的快速流行和传统癌症治疗的有限疗效推动了对基因治疗等新型治疗方法的需求，基因治疗为在基因层面上靶向和精确治疗癌症提供了潜力。随着对癌症生物学、肿瘤异质性和肿瘤发生的分子机制的日益了解，人们越来越重视开发针对特定基因突变、癌基因和与癌症进展有关的信号通路的基因治疗策略。此外，CRISPR/Cas9、TALEN 和锌指核酸酶等基因编辑技术的出现使得能够精确修饰癌症相关基因，为开发破坏致癌途径、增强肿瘤抑制和改善患者预后的基因疗法提供了新的机会。

此外，用于基因传递的病毒和非病毒载体的不断增加、载体工程的进步以及基因转移技术的优化推动了更安全、更有效和有针对性的癌症基因治疗的发展。此外，对癌症研究、临床试验和基因治疗产品监管许可的投资不断增加，促进了癌症基因治疗市场的创新和商业化。基因疗法具有彻底改变癌症治疗模式的潜力，为患有难治性癌症、罕见遗传性疾病和未满足的医疗需求的患者带来了新的希望，推动了人们对这个快速发展的领域的兴趣和投资。

然而，严格的监管要求、临床试验的复杂性和伦理问题可能会挑战癌症基因治疗市场的成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球癌症基因治疗市场的各个细分市场进行了包容性评估。癌症基因治疗产业的成长和趋势为这项研究提供了整体方法。

市场区隔

癌症基因治疗市场报告的这一部分提供了国家和地区层面细分市场的详细资料，从而帮助策略家确定相应产品或服务的目标人口统计数据以及即将到来的机会。

透过治疗

  • 溶瘤病毒疗法
  • 基因诱导免疫疗法
  • 基因转移

按最终用途

  • 研究机构
  • 生物製药公司
  • 诊断中心
  • 其他的

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲癌症基因治疗市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。癌症基因治疗市场的主要参与者包括Abeona Therapeutics Inc.、Asklepios BioPharmaceutical Inc.、Altor Bioscience Inc.、Bluebird bio Inc.、BioCancell Inc.、Celgene Inc.、Elevate Bio Inc.、GlaxoSmithKline Inc.、Genelux Corporation、 GenVecec 、Introgen Therapeutics Inc.、Merck KGaA、OncoGenex Pharmaceuticals Inc. 本部分包含竞争格局的整体视图，其中包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概览、合作、新产品开发、新产品发布以及其他进展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法论
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：癌症基因治疗 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按治疗方法进行的市场吸引力分析
    • 按最终用途分類的市场吸引力分析
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：全球癌症基因治疗市场分析：依治疗分类

  • 治疗概述
  • 历史和预测数据
  • 治疗分析
  • 溶瘤病毒疗法
  • 基因诱导免疫疗法
  • 基因转移

第 6 章：全球癌症基因治疗市场分析：依最终用途分类

  • 按最终用途分类的概述
  • 历史和预测数据
  • 按最终用途分析
  • 研究机构
  • 生物製药公司
  • 诊断中心
  • 其他的

第 7 章：全球癌症基因治疗市场分析：依地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区按国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲按国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 8 章：癌症基因治疗公司的竞争格局

  • 癌症基因治疗市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 9 章：公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Abeona Therapeutics Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Asklepios BioPharmaceutical Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Altor Bioscience Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Bluebird Bio Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • BioCancell Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Celgene Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Elevate Bio Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • GlaxoSmithKline Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Genelux Corporation
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • GenVec
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Introgen Therapeutics Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Merck KGaA
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • OncoGenex Pharmaceuticals Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展

註 - 在公司概况中，财务详细资料和最新进展视情况而定，或对私人公司而言可能不包括在内

Product Code: VMR112114339

The global demand for Cancer Gene Therapy Market is presumed to reach the market size of nearly USD 16.1 Billion by 2032 from USD 3.11 Billion in 2023 with a CAGR of 20.05% under the study period 2024 - 2032.

Cancer gene therapy uses genetic techniques to treat cancer by targeting specific genes or cellular pathways involved in tumor growth, progression, and survival. This therapeutic approach aims to modify or suppress cancer-related genes, stimulate immune responses against cancer cells, or deliver therapeutic genes directly into tumors to inhibit their growth or induce cell death. This therapy holds promise as a potential treatment option for various types of cancer, including solid tumors and hematological malignancies, offering the potential for targeted and personalized interventions with reduced toxicity compared to traditional chemotherapy and radiation therapy.

MARKET DYNAMICS

The spurring prevalence of cancer worldwide and the limited efficacy of conventional cancer treatments drive the demand for novel therapeutic approaches such as gene therapy, which offers the potential for targeted and precise treatment of cancer at the genetic level. With the growing understanding of cancer biology, tumor heterogeneity, and molecular mechanisms of oncogenesis, there is an increasing emphasis on developing gene therapy strategies that target specific genetic mutations, oncogenes, and signaling pathways implicated in cancer progression. Additionally, the advent of gene editing technologies such as CRISPR/Cas9, TALENs, and zinc finger nucleases enables precise modification of cancer-related genes, offering new opportunities for developing gene therapies that disrupt oncogenic pathways, enhance tumor suppression, and improve patient outcomes.

Moreover, the increasing availability of viral and non-viral vectors for gene delivery, advancements in vector engineering, and optimization of gene transfer techniques drive the development of safer, more efficient, and targeted cancer gene therapy. Furthermore, the growing investment in cancer research, clinical trials, and regulatory clearances for gene therapy products foster innovation and commercialization in the cancer gene therapy market. With the potential to revolutionize cancer treatment paradigms, gene therapy provides new hope for patients with refractory cancers, rare genetic disorders, and unmet medical needs, driving interest and investment in this rapidly evolving field.

However, stringent regulatory requirements, clinical trial complexities, and ethical concerns may challenge the growth of the cancer gene therapy market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of cancer gene therapy. The growth and trends of cancer gene therapy industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the cancer gene therapy market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Therapy

  • Oncolytic Virotherapy
  • Gene Induced Immunotherapy
  • Gene Transfer

By End-Use

  • Research Institutes
  • Biopharmaceutical Companies
  • Diagnostic Centers
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Cancer Gene Therapy market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Cancer Gene Therapy market include Abeona Therapeutics Inc., Asklepios BioPharmaceutical Inc., Altor Bioscience Inc., Bluebird bio Inc., BioCancell Inc., Celgene Inc., Elevate Bio Inc., GlaxoSmithKline Inc., Genelux Corporation, GenVec, Introgen Therapeutics Inc., Merck KGaA, OncoGenex Pharmaceuticals Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. CANCER GENE THERAPY - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Therapy
    • 3.7.2 Market Attractiveness Analysis By End-use
    • 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL CANCER GENE THERAPY MARKET ANALYSIS BY THERAPY

  • 5.1. Overview By Therapy
  • 5.2. Historical and Forecast Data
  • 5.3. Analysis By Therapy
  • 5.4. Oncolytic Virotherapy Historic and Forecast Sales By Regions
  • 5.5. Gene Induced Immunotherapy Historic and Forecast Sales By Regions
  • 5.6. Gene Transfer Historic and Forecast Sales By Regions

6. GLOBAL CANCER GENE THERAPY MARKET ANALYSIS BY END-USE

  • 6.1. Overview By End-use
  • 6.2. Historical and Forecast Data
  • 6.3. Analysis By End-use
  • 6.4. Research Institutes Historic and Forecast Sales By Regions
  • 6.5. Biopharmaceutical Companies Historic and Forecast Sales By Regions
  • 6.6. Diagnostic Centers Historic and Forecast Sales By Regions
  • 6.7. Others Historic and Forecast Sales By Regions

7. GLOBAL CANCER GENE THERAPY MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2 North America By Segment Sales Analysis
    • 7.3.3 North America By Country Sales Analysis
    • 7.3.4 United States Sales Analysis
    • 7.3.5 Canada Sales Analysis
    • 7.3.6 Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2 Europe By Segment Sales Analysis
    • 7.4.3 Europe By Country Sales Analysis
    • 7.4.4 United Kingdom Sales Analysis
    • 7.4.5 France Sales Analysis
    • 7.4.6 Germany Sales Analysis
    • 7.4.7 Italy Sales Analysis
    • 7.4.8 Russia Sales Analysis
    • 7.4.9 Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2 Asia Pacific By Segment Sales Analysis
    • 7.5.3 Asia Pacific By Country Sales Analysis
    • 7.5.4 China Sales Analysis
    • 7.5.5 India Sales Analysis
    • 7.5.6 Japan Sales Analysis
    • 7.5.7 South Korea Sales Analysis
    • 7.5.8 Australia Sales Analysis
    • 7.5.9 South East Asia Sales Analysis
    • 7.5.10 Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2 Latin America By Segment Sales Analysis
    • 7.6.3 Latin America By Country Sales Analysis
    • 7.6.4 Brazil Sales Analysis
    • 7.6.5 Argentina Sales Analysis
    • 7.6.6 Peru Sales Analysis
    • 7.6.7 Chile Sales Analysis
    • 7.6.8 Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2 Middle East & Africa By Segment Sales Analysis
    • 7.7.3 Middle East & Africa By Country Sales Analysis
    • 7.7.4 Saudi Arabia Sales Analysis
    • 7.7.5 UAE Sales Analysis
    • 7.7.6 Israel Sales Analysis
    • 7.7.7 South Africa Sales Analysis
    • 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE CANCER GENE THERAPY COMPANIES

  • 8.1. Cancer Gene Therapy Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9. COMPANY PROFILES OF CANCER GENE THERAPY INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Abeona Therapeutics Inc.
    • 9.3.1 Company Overview
    • 9.3.2 Company Revenue
    • 9.3.3 Products
    • 9.3.4 Recent Developments
  • 9.4. Asklepios BioPharmaceutical Inc.
    • 9.4.1 Company Overview
    • 9.4.2 Company Revenue
    • 9.4.3 Products
    • 9.4.4 Recent Developments
  • 9.5. Altor Bioscience Inc.
    • 9.5.1 Company Overview
    • 9.5.2 Company Revenue
    • 9.5.3 Products
    • 9.5.4 Recent Developments
  • 9.6. Bluebird Bio Inc.
    • 9.6.1 Company Overview
    • 9.6.2 Company Revenue
    • 9.6.3 Products
    • 9.6.4 Recent Developments
  • 9.7. BioCancell Inc.
    • 9.7.1 Company Overview
    • 9.7.2 Company Revenue
    • 9.7.3 Products
    • 9.7.4 Recent Developments
  • 9.8. Celgene Inc.
    • 9.8.1 Company Overview
    • 9.8.2 Company Revenue
    • 9.8.3 Products
    • 9.8.4 Recent Developments
  • 9.9. Elevate Bio Inc.
    • 9.9.1 Company Overview
    • 9.9.2 Company Revenue
    • 9.9.3 Products
    • 9.9.4 Recent Developments
  • 9.10. GlaxoSmithKline Inc.
    • 9.10.1 Company Overview
    • 9.10.2 Company Revenue
    • 9.10.3 Products
    • 9.10.4 Recent Developments
  • 9.11. Genelux Corporation
    • 9.11.1 Company Overview
    • 9.11.2 Company Revenue
    • 9.11.3 Products
    • 9.11.4 Recent Developments
  • 9.12. GenVec
    • 9.12.1 Company Overview
    • 9.12.2 Company Revenue
    • 9.12.3 Products
    • 9.12.4 Recent Developments
  • 9.13. Introgen Therapeutics Inc.
    • 9.13.1 Company Overview
    • 9.13.2 Company Revenue
    • 9.13.3 Products
    • 9.13.4 Recent Developments
  • 9.14. Merck KGaA
    • 9.14.1 Company Overview
    • 9.14.2 Company Revenue
    • 9.14.3 Products
    • 9.14.4 Recent Developments
  • 9.15. OncoGenex Pharmaceuticals Inc.
    • 9.15.1 Company Overview
    • 9.15.2 Company Revenue
    • 9.15.3 Products
    • 9.15.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Therapy (USD MN)
  • Oncolytic Virotherapy Market Sales By Geography (USD MN)
  • Gene Induced Immunotherapy Market Sales By Geography (USD MN)
  • Gene Transfer Market Sales By Geography (USD MN)
  • Analysis By End-use (USD MN)
  • Research Institutes Market Sales By Geography (USD MN)
  • Biopharmaceutical Companies Market Sales By Geography (USD MN)
  • Diagnostic Centers Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Cancer Gene Therapy Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Cancer Gene Therapy Report
  • Market Research Process
  • Market Research Methodology
  • Global Cancer Gene Therapy Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Therapy
  • Market Attractiveness Analysis By End-use
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Therapy (USD MN)
  • Oncolytic Virotherapy Market Sales By Geography (USD MN)
  • Gene Induced Immunotherapy Market Sales By Geography (USD MN)
  • Gene Transfer Market Sales By Geography (USD MN)
  • Global Market Analysis By End-use (USD MN)
  • Research Institutes Market Sales By Geography (USD MN)
  • Biopharmaceutical Companies Market Sales By Geography (USD MN)
  • Diagnostic Centers Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.